Treatment retention of infliximab and etanercept originators versus their corresponding biosimilars: Nordic collaborative observational study of 2334 biologics naïve patients with spondyloarthritis.
Saved in:
| Title: | Treatment retention of infliximab and etanercept originators versus their corresponding biosimilars: Nordic collaborative observational study of 2334 biologics naïve patients with spondyloarthritis. |
|---|---|
| Authors: | Lindström U; Department of Rheumatology and Inflammation Research, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden., Glintborg B; DANBIO and Copenhagen Center for Arthritis Research (COPECARE), Center for Rheumatology and Spine Diseases, Centre of Head and Orthopedics, Rigshospitalet Glostrup, Glostrup, Denmark.; Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark., Di Giuseppe D; Clinical Epidemiology Unit, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden., Nordström D; Department of Medicine, Helsinki University and Helsinki University Hospital, Helsinki, Finland., Aarrestad Provan S; Rheumatology, Diakonhjemmet Hospital, Oslo, Norway., Gudbjornsson B; Centre for Rheumatology Research, University Hospital and Faculty of Medicine, University of Iceland, Reykjavik, Iceland., Askling J; Clinical Epidemiology Unit, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden., Lund Hetland M; DANBIO and Copenhagen Center for Arthritis Research (COPECARE), Center for Rheumatology and Spine Diseases, Centre of Head and Orthopedics, Rigshospitalet Glostrup, Glostrup, Denmark.; Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark., Aaltonen K; Pharmaceuticals Pricing Board, Ministry of Social Affairs and Health, Helsinki, Finland., Krogh NS; Zitelab Aps, Copenhagen, Denmark., Geirsson AJ; Department of Rheumatology, University Hospital, Reykjavik, Iceland., Jacobsson LTH; Department of Rheumatology and Inflammation Research, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden. |
| Source: | RMD open [RMD Open] 2019 Oct 23; Vol. 5 (2), pp. e001079. Date of Electronic Publication: 2019 Oct 23 (Print Publication: 2019). |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't; Observational Study |
| Journal Info: | Publisher: BMJ Publishing Group Country of Publication: England NLM ID: 101662038 Publication Model: eCollection Cited Medium: Internet ISSN: 2056-5933 (Electronic) Linking ISSN: 20565933 NLM ISO Abbreviation: RMD Open Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 31749988 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Treatment retention of infliximab and etanercept originators versus their corresponding biosimilars: Nordic collaborative observational study of 2334 biologics naïve patients with spondyloarthritis. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Lindström+U%22">Lindström U</searchLink>; Department of Rheumatology and Inflammation Research, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.<br /><searchLink fieldCode="AU" term="%22Glintborg+B%22">Glintborg B</searchLink>; DANBIO and Copenhagen Center for Arthritis Research (COPECARE), Center for Rheumatology and Spine Diseases, Centre of Head and Orthopedics, Rigshospitalet Glostrup, Glostrup, Denmark.; Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.<br /><searchLink fieldCode="AU" term="%22Di+Giuseppe+D%22">Di Giuseppe D</searchLink>; Clinical Epidemiology Unit, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden.<br /><searchLink fieldCode="AU" term="%22Nordström+D%22">Nordström D</searchLink>; Department of Medicine, Helsinki University and Helsinki University Hospital, Helsinki, Finland.<br /><searchLink fieldCode="AU" term="%22Aarrestad+Provan+S%22">Aarrestad Provan S</searchLink>; Rheumatology, Diakonhjemmet Hospital, Oslo, Norway.<br /><searchLink fieldCode="AU" term="%22Gudbjornsson+B%22">Gudbjornsson B</searchLink>; Centre for Rheumatology Research, University Hospital and Faculty of Medicine, University of Iceland, Reykjavik, Iceland.<br /><searchLink fieldCode="AU" term="%22Askling+J%22">Askling J</searchLink>; Clinical Epidemiology Unit, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden.<br /><searchLink fieldCode="AU" term="%22Lund+Hetland+M%22">Lund Hetland M</searchLink>; DANBIO and Copenhagen Center for Arthritis Research (COPECARE), Center for Rheumatology and Spine Diseases, Centre of Head and Orthopedics, Rigshospitalet Glostrup, Glostrup, Denmark.; Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.<br /><searchLink fieldCode="AU" term="%22Aaltonen+K%22">Aaltonen K</searchLink>; Pharmaceuticals Pricing Board, Ministry of Social Affairs and Health, Helsinki, Finland.<br /><searchLink fieldCode="AU" term="%22Krogh+NS%22">Krogh NS</searchLink>; Zitelab Aps, Copenhagen, Denmark.<br /><searchLink fieldCode="AU" term="%22Geirsson+AJ%22">Geirsson AJ</searchLink>; Department of Rheumatology, University Hospital, Reykjavik, Iceland.<br /><searchLink fieldCode="AU" term="%22Jacobsson+LTH%22">Jacobsson LTH</searchLink>; Department of Rheumatology and Inflammation Research, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101662038%22">RMD open</searchLink> [RMD Open] 2019 Oct 23; Vol. 5 (2), pp. e001079. <i>Date of Electronic Publication: </i>2019 Oct 23 (<i>Print Publication: </i>2019). – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Research Support, Non-U.S. Gov't; Observational Study – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22BMJ+Publishing+Group%22">BMJ Publishing Group </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101662038 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Internet <i>ISSN: </i>2056-5933 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2220565933%22">20565933 </searchLink><i>NLM ISO Abbreviation: </i>RMD Open <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=31749988 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1136/rmdopen-2019-001079 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: e001079 Titles: – TitleFull: Treatment retention of infliximab and etanercept originators versus their corresponding biosimilars: Nordic collaborative observational study of 2334 biologics naïve patients with spondyloarthritis. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Lindström U – PersonEntity: Name: NameFull: Glintborg B – PersonEntity: Name: NameFull: Di Giuseppe D – PersonEntity: Name: NameFull: Nordström D – PersonEntity: Name: NameFull: Aarrestad Provan S – PersonEntity: Name: NameFull: Gudbjornsson B – PersonEntity: Name: NameFull: Askling J – PersonEntity: Name: NameFull: Lund Hetland M – PersonEntity: Name: NameFull: Aaltonen K – PersonEntity: Name: NameFull: Krogh NS – PersonEntity: Name: NameFull: Geirsson AJ – PersonEntity: Name: NameFull: Jacobsson LTH IsPartOfRelationships: – BibEntity: Dates: – D: 23 M: 10 Text: 2019 Oct 23 Type: published Y: 2019 Identifiers: – Type: issn-electronic Value: 2056-5933 Numbering: – Type: volume Value: 5 – Type: issue Value: 2 Titles: – TitleFull: RMD open Type: main |
| ResultId | 1 |
